Dimensional Fund Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
412,246
-6,308
| -2% | -$28.5K | ﹤0.01% | 2776 |
|
|
2025
Q1 | $1.86M | Sell |
418,554
-44,681
| -10% | -$198K | ﹤0.01% | 2745 |
|
|
2024
Q4 | $3.63M | Sell |
463,235
-14,429
| -3% | -$113K | ﹤0.01% | 2629 |
|
|
2024
Q3 | $6.28M | Sell |
477,664
-6,767
| -1% | -$89K | ﹤0.01% | 2455 |
|
|
2024
Q2 | $5.85M | Buy |
484,431
+65,732
| +16% | +$794K | ﹤0.01% | 2445 |
|
|
2024
Q1 | $6.81M | Buy |
418,699
+105,598
| +34% | +$1.72M | ﹤0.01% | 2465 |
|
|
2023
Q4 | $2.14M | Buy |
313,101
+71,512
| +30% | +$488K | ﹤0.01% | 2776 |
|
|
2023
Q3 | $1.32M | Buy |
241,589
+112,091
| +87% | +$611K | ﹤0.01% | 2862 |
|
|
2023
Q2 | $879K | Buy |
129,498
+20,066
| +18% | +$136K | ﹤0.01% | 2951 |
|
|
2023
Q1 | $548K | Sell |
109,432
-11,704
| -10% | -$58.6K | ﹤0.01% | 3015 |
|
|
2022
Q4 | $592 | Sell |
121,136
-11,475
| -9% | -$56 | ﹤0.01% | 3007 |
|
|
2022
Q3 | $1.91M | Sell |
132,611
-87,356
| -40% | -$1.26M | ﹤0.01% | 2721 |
|
|
2022
Q2 | $3.33M | Buy |
219,967
+36,599
| +20% | +$554K | ﹤0.01% | 2583 |
|
|
2022
Q1 | $2.18M | Sell |
183,368
-8,434
| -4% | -$100K | ﹤0.01% | 2805 |
|
|
2021
Q4 | $3.11M | Buy |
191,802
+66,280
| +53% | +$1.07M | ﹤0.01% | 2718 |
|
|
2021
Q3 | $3.58M | Buy |
+125,522
| New | +$3.58M | ﹤0.01% | 2675 |
|